Show simple item record

dc.contributor.advisorChowdhury, Namara Mariam
dc.contributor.authorGhosh, Dibbo Protim
dc.date.accessioned2024-08-27T09:35:35Z
dc.date.available2024-08-27T09:35:35Z
dc.date.copyright©2024
dc.date.issued2024-03
dc.identifier.otherID 20146027
dc.identifier.urihttp://hdl.handle.net/10361/23927
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.en_US
dc.descriptionCataloged from the PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 55-59).
dc.description.abstractEpilepsy currently affects about 50 million people and approximately 10% of the population will have at least one seizure during their lifetime yet very little is known about this condition. This condition can occur as a result of various causes and has multiple proposed pathogenesis. There are multiple types of epilepsy and as of now there is no cure. Even treatment for many types of epilepsy is not available. Ganaxolone is a new anti-seizure medication which has been approved by the USFDA for the treatment for CDD associated epilepsy, it is a first drug in its class. It has shown great promise in the clinical trials as it is effective against treatment resistant epilepsy and exhibits lower side effects and drug interactions. In this review, the clinical trial data of ganaxolone is analyzed and an evaluation of its effectiveness over currently available treatment is provided which can be used to unravel the full potential of this drug in the future.en_US
dc.description.statementofresponsibilityDibbo Protim Ghosh
dc.format.extent59 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectGanaxoloneen_US
dc.subjectCDKL5 deficiency disorderen_US
dc.subjectEpilepsyen_US
dc.subjectAnti-seizure medicationen_US
dc.subject.lcshEpilepsy--Treatment.
dc.titleA review on the use of Ganaxolone in the treatment of Epilepsyen_US
dc.typeThesisen_US
dc.contributor.departmentSchool of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record